Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,147,101 papers from all fields of science
Search
Sign In
Create Free Account
isoprodian
Known as:
4-pyridinecarboxylic acid hydrazide mixture with 2-propyl-4-pyridinecarbothioamide and 4,4'-sulfonylbis(benzenamine)
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (4)
Dapsone
Drug Combinations
Prothionamide
isoniazid
Narrower (1)
L73A
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project.
R. Jacobson
,
P. Gatt
Leprosy Review
2008
Corpus ID: 1449906
The Malta Leprosy Eradication Project (MLEP) was proposed in 1971 by Freerksen with the aim of eradicating leprosy in Malta. The…
Expand
1989
1989
New forms of multidrug therapy for the treatment of leprosy. First report for the practice on rifampicin + sulfamethoxazole-trimethoprim + protionamide and rifampicin + sulfamethoxazole-trimethoprim…
E. Freerksen
,
M. Rosenfeld
,
G. Spannuth
Chemotherapy
1989
Corpus ID: 46740071
Since 1970, when the lifelong monotherapy with dapsone (DDS) in leprosy could be replaced by short-term combination therapy with…
Expand
1986
1986
The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.
G. Depasquale
Leprosy Review
1986
Corpus ID: 26159224
1985
1985
Failure of a prothionamide-containing oral antituberculosis regimen.
M. Langton
,
R. Cowie
South African medical journal = Suid-Afrikaanse…
1985
Corpus ID: 19957001
A group of 150 patients with sputum-positive pulmonary tuberculosis was treated with a regimen containing only orally…
Expand
1982
1982
Bacterial growth kinetics of "M. lufu" in the presence and absence of various drugs alone and in combination. A model for the development of combined chemotherapy against M. leprae?
J. Seydel
,
E. Wempe
International journal of leprosy and other…
1982
Corpus ID: 5995956
Bacterial growth kinetic studies were performed in a series of potential inhibitors of M. leprae using "M. lufu" as a model…
Expand
1982
1982
Bacterial growth kinetics of "M. lufu" in the presence and absence of various drugs alone and in combination. A model for the development of combined chemotherapy against M. leprae?
Seydel Jk
,
Wempe Eg
1982
Corpus ID: 222314493
: Bacterial growth kinetic studies were performed in a series of potential inhibitors of M. leprae using "M. lufu" as a model…
Expand
1979
1979
On the mechanism of the antimycobacterial activity of isoniazid + prothionamide + dapsone (Isoprodian).
R. Urbanczik
Chemotherapy
1979
Corpus ID: 23258466
Increased antimycobacterial activity of Isoprodian (isoniazid + prothionamide + dapsone) may be due to (i) decreased mutation…
Expand
1979
1979
[Long-term treatment of tuberculosis with isoprodian (author's transl)].
O. Bergsmann
,
E. Spielmann
Wiener Klinische Wochenschrift
1979
Corpus ID: 33199498
The results of combination therapy of Isoprodian with ethambul in patients with severe pulmonary tuberculosis were found to be…
Expand
1976
1976
Preliminary Experiences with Isoprodian(R) in the Treatment of Pulmonary Tuberculosis
H. Blaha
,
W. Müller
1976
Corpus ID: 68246595
The WHO Committee on Tuberculosis emphasized in its last report (1974) the importance to secure adequate chemotherapy to every…
Expand
1975
1975
Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
H. N. Krenzien
Leprosy Review
1975
Corpus ID: 1971533
Sixty-seven patients with lepromatous leprosy were given combined treatment with rifampicin and lsoprodian at Balaka Leprosy…
Expand